Noom Introduces At-Home Biomarker Test Kit for Metabolic and Cardiovascular Health Tracking
Noom, a leader in digital health and behavior change, has launched a $125 at-home Biomarkers Test Kit for its U.S. members. This kit is designed to provide comprehensive tracking of metabolic and cardiovascular health. Utilizing the Tasso+ device, the kit allows for painless blood collection and tracks 17 clinically significant biomarkers, including HbA1c, ApoB, triglycerides, and hs-CRP. The initiative aims to address the gap in traditional health monitoring, which often relies on episodic care models. Noom's approach integrates real-time feedback into its app, allowing users to monitor their health metrics continuously. This development is part of Noom's broader strategy to integrate at-home diagnostics with personalized behavior change algorithms, creating a digital ecosystem for health management. 
